SEC FORM 3

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Stimson Susan P

(Last)

(First)

(Middle)

C/O INTERSECT ENT, INC.

1555 ADAMS DRIVE

(Street)

MENLO PARK

94025

(City)

(State)

(Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
10/29/2018

3. Issuer Name and Ticker or Trading Symbol
Intersect ENT, Inc. [ XENT ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	Chief Strategy Officer

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	36,203⁽¹⁾	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivative Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
Stock Options (Right to buy)	⁽²⁾	02/28/2028	Common Stock	21,000	$35.9	D
Stock Options (Right to buy)	⁽³⁾	01/20/2025	Common Stock	25,000	$21.06	D
Stock Options (Right to buy)	⁽⁴⁾	01/14/2026	Common Stock	25,000	$18.9	D
Stock Options (Right to buy)	⁽⁵⁾	01/17/2027	Common Stock	24,500	$13.05	D
Stock Options (Right to buy)	⁽⁶⁾	04/22/2023	Common Stock	10,938	$1.2	D

Explanation of Responses:

1. Includes 8,033 Restricted Stock Units. Each restricted stock unit represents a right to receive one share of Intersect ENT, Inc. common stock upon vesting. 3,266 units vest on March 1, 2019, 3,267 units vest on March 1, 2020 and 1,500 units vest on March 1, 2021.

2. The vesting commencement date of the option is March 1, 2018. 1/8th of the shares subject to the option shall vest on September 1, 2018 and 1/48th of the shares subject to the option shall vest monthly thereafter over 42 months.

3. The vesting commencement date of the option is January 21, 2015. 1/8th of the shares subject to the option shall vest on July 21, 2015 and 1/48th of the shares subject to the option shall vest monthly thereafter over 42 months.

4. The shares subject to the option vest monthly over four years commencing on January 1, 2016.

5. The vesting commencement date of the option is March 1, 2017. 1/8th of the shares subject to the option shall vest on September 1, 2017 and 1/48th of the shares subject to the option shall vest monthly thereafter over 42 months.

6. The shares subject to the option vest monthly over four years commencing on April 23, 2013.

Remarks:

	/s/ David A. Lehman, Attorney-in-Fact for Stimson Susan P	11/07/2018
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.